DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesDBVTF
Q2 2023 vs. Q1 2023
How the institutions holding DBV Technologies S.A. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 34 | 36 | +2 |
| Shares | 42.2M | 46.0M | +3.77M (+8.9%) |
| Value | $71.3M | $87.4M | +$16.1M (+22.5%) |
New holders (6)
Institutions that held DBV Technologies S.A. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 3,112,500 | $5.91M | 0.02% |
| Logos Global Management LP | 1,200,000 | $2.28M | 0.31% |
| Optiver Holding B.V. | 39,537 | $75.1K | 0.00% |
| Rhumbline Advisers | 28,999 | $55.1K | 0.00% |
| Citadel Advisors LLC | 28,901 | $54.9K | 0.00% |
| Lynx1 Capital Management LP | 18,265 | $34.7K | 0.02% |
Sold out (4)
Institutions that held DBV Technologies S.A. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Old Mission Capital LLC | 30,597 | $51.7K |
| Tower Research Capital LLC (TRC) | 7,233 | $12.0K |
| Advisory Services Network, LLC | 1,000 | $1.69K |
| TCI Wealth Advisors, Inc. | 20 | $34 |